A clinical trial suggesting the heart benefits of the controversial treatment draws criticism from the scientific community.
The Scientist
Most Recent
Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.
The malaria vaccine under development by GSK and the PATH initiative only protects about one in three babies, though some researchers say those odds are better than nothing.
Inflammatory signals in injured zebrafish brains promote the growth of new neurons.
Mice fed a mix of six strains of bacteria were able to fight a C. difficile infection that causes deadly diarrhea and is resistant to most types of treatment.
A magnesium supplement thought to improve brain functioning gets a small clinical trial.
A large-scale statistical analysis shows that medical studies revealing “very large effects” seldom stand up when other researchers try to replicate them.
Viral DNA in mice genomes may lead to cancer in immune-compromised animals.
Another clinical trial raises concerns about the efficacy and safety of a common intravenous treatment for patients that have lost large amounts of blood.
GlaxoSmithKline will share long-sought, raw trial data—but access will be tightly controlled.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
